PARATEK PHARMACEUTICALS INC - FORM S-1/A - EX-23.3 - CONSENT OF LOUISE MAWHINNEY AS A DIRECTOR NOMINEE - October 12, 2012

Attached files

file filename
S-1/A - FORM S-1/A AMENDMENT NO. 1 - PARATEK PHARMACEUTICALS INCd386058ds1a.htm
EX-4.4 - THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT - PARATEK PHARMACEUTICALS INCd386058dex44.htm
EX-3.2 - FORM OF RESTATED CERTIFICATE OF INCORPORATION - PARATEK PHARMACEUTICALS INCd386058dex32.htm
EX-3.4 - FORM OF RESTATED BY-LAWS OF THE REGISTRANT - PARATEK PHARMACEUTICALS INCd386058dex34.htm
EX-3.1.2 - CERTIFICATE OF AMENDMENT TO THE THIRD AMENDED AND RESTATED CERTIFICATE OF INCORP - PARATEK PHARMACEUTICALS INCd386058dex312.htm
EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS, LLP - PARATEK PHARMACEUTICALS INCd386058dex231.htm
EX-10.3.1 - 2012 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK PLAN - PARATEK PHARMACEUTICALS INCd386058dex1031.htm
EX-10.23 - 2012 EMPLOYEE STOCK PURCHASE PLAN - PARATEK PHARMACEUTICALS INCd386058dex1023.htm
EX-10.24 - FORM OF INDEMNIFICATION AGREEMENT FOR OFFICERS AND DIRECTORS - PARATEK PHARMACEUTICALS INCd386058dex1024.htm
EX-10.3.2 - FORM OF STOCK OPTION AGREEMENT - PARATEK PHARMACEUTICALS INCd386058dex1032.htm

Exhibit 23.3

CONSENT

The undersigned hereby consents to being named in the registration statement on Form S-1 (Registration No. 333-184142) and in all subsequent amendments and post-effective amendments or supplements thereto and in any registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act (the “Registration Statement”) of Paratek Pharmaceuticals, Inc., a Delaware corporation (the “Company”), as an individual to become a director of the Company and to the inclusion of her biographical information in the Registration Statement.

Dated: October 11, 2012

/s/ Louise Mawhinney            

Louise Mawhinney